Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Rights groups condemn Israel Police decision to ban Sudan Genocide protests nationwide - 2UAE recalls some Nestle infant formula products, Qatar warns consumers
- 3Instructions to Expand Your Advantages from an Open Record Reward
- 425 of the world’s best sandwiches
- 5The Best Web-based Courses for Expertise Improvement
- A 'rampaging lion' nebula roars to life in a stunning deep-space photo
- Everyone knows F1 is for the girls. I wandered into the Las Vegas desert to find out why.
- Police arrest 18 as anti-war protests spread across Tel Aviv, Haifa, Jerusalem
- Pocket-Accommodating Jeep Wrangler Buying Guide for Seniors
- Malaysia To Revive Search for Missing Flight MH370
- Colorado residents face earliest water restrictions ever — a harbinger of worse to come
- Mickey Lee of 'Big Brother' fame dead at 35 after flu complications, family says
- Germany's first Omani LNG shipments arrive despite Middle East disruptions
- The Electric Bicycle Americans Can Confide in 2024
